Evaluation of Efficacy, Safety and Immunogenicity of GX-19N in Healthy Individuals Who Have Received COVID-19 Vaccines

Clinical trial NCT05067946 · WITHDRAWN

Trial details

NCT number: NCT05067946
Sponsor: Genexine, Inc.
Status: WITHDRAWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

SARS-CoV2 Infection

Start date: 2021-10-01
Primary completion: 2022-10-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.